After the preliminary analysis of the effectiveness of the Russian vaccine Sputnik V was published in the journal “The Lancet”, interest in the vaccine increased in many Western countries.
Kirill Dmitriev, head of the multi-billion dollar "Russian Fund for Direct Investment" has taken over the marketing.
The father of success is now referred to as Mr. Sputnik V in Russia.
He showed an unusual willingness to take risks for the project - and can also rely on a special trump card.